Zoster vaccine recommendations: The importance of using a clinically valid correlate of protection

Michael N. Oxman; Anne A. Gershon; Gregory A. Poland

doi:10.1016/j.vaccine.2011.04.019

Zoster vaccine recommendations: The importance of using a clinically valid correlate of protection

Michael N. Oxman, Anne A. Gershon, Gregory A. Poland

General Internal Medicine

Research output: Contribution to journal › Editorial

10 Scopus citations

Original language	English (US)
Pages (from-to)	3625-3627
Number of pages	3
Journal	Vaccine
Volume	29
Issue number	20
DOIs	https://doi.org/10.1016/j.vaccine.2011.04.019
State	Published - May 9 2011

ASJC Scopus subject areas

Molecular Medicine
Immunology and Microbiology(all)
veterinary(all)
Public Health, Environmental and Occupational Health
Infectious Diseases

Cite this

Oxman, M. N., Gershon, A. A., & Poland, G. A. (2011). Zoster vaccine recommendations: The importance of using a clinically valid correlate of protection. Vaccine, 29(20), 3625-3627. https://doi.org/10.1016/j.vaccine.2011.04.019

@article{278fc75f7f4c49acac3b06692dfb74ae,

title = "Zoster vaccine recommendations: The importance of using a clinically valid correlate of protection",

author = "Oxman, {Michael N.} and Gershon, {Anne A.} and Poland, {Gregory A.}",

year = "2011",

month = may

day = "9",

doi = "10.1016/j.vaccine.2011.04.019",

language = "English (US)",

volume = "29",

pages = "3625--3627",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "20",

}

TY - JOUR

T1 - Zoster vaccine recommendations

T2 - The importance of using a clinically valid correlate of protection

AU - Oxman, Michael N.

AU - Gershon, Anne A.

AU - Poland, Gregory A.

PY - 2011/5/9

Y1 - 2011/5/9

UR - http://www.scopus.com/inward/record.url?scp=79955098203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955098203&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2011.04.019

DO - 10.1016/j.vaccine.2011.04.019

M3 - Editorial

C2 - 21524565

AN - SCOPUS:79955098203

VL - 29

SP - 3625

EP - 3627

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 20

ER -

Access to Document

10.1016/j.vaccine.2011.04.019